Inhibin expression in normal and pre-eclamptic placental tissue

International Journal of Gynecological Pathology

Volumn 19, Issue 3, 2000, Pages 219-224

  Jackson, N ^a,c   Biddolph, S C ^a   Ledger, W ^a   Groome, N P ^b   Manek, S ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b OXFORD BROOKES UNIVERSITY   (United Kingdom)

^c QUEEN CHARLOTTE S AND CHELSEA HOSPITAL   (United Kingdom)

Author keywords

Immunohistochemistry; Inhibin; Placenta; Pre eclampsia

Indexed keywords

INHIBIN;

ARTICLE; CONTROLLED STUDY; CYTOPLASM; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PLACENTA; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; SYNCYTIOTROPHOBLAST; TROPHOBLAST;

EID: 0033938770     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004347-200007000-00004     Document Type: Article

References (15)

1. McLachlan RI, Healy DL, Lutjen PJ, Findlay JK, De Kretser M, Burger HG. The maternal ovary is not the source of circulating inhibin levels during human pregnancy. Clin Endocrinol 1987;27: 663-8.
2. Birdsall M, Ledger W, Groome NP, Abdalla H, Muttukrishna S. Inhibin A and activin A in the first trimester of human pregnancy. J Clin Endocrinol Metab 1997;82:1557-60.
3. Muttukrishna S, Child TJ, Groome NP, Ledger WL. Source of circulating levels of inhibin A, pro alpha C-containing inhibins and activin A in early pregnancy. Hum Reprod 1997;12:1089-93.
4. Khalil A, Kaufmann RC, Wortsmann J, Winters SJ, Huffman DG. Inhibin in normal and abnormal pregnancy: Maternal serum concentration and partial characterization. Am J Obstet Gynecol 1995; 172:1019-25.
5. Muttukrishna S, Knight PG, Groome NP, Redman CW, Ledger WL. Activin A and inhibin A as possible endocrine markers for pre-eclampsia. Lancet 1997;349:1285-8.
6. Silver HM, Lambert-Messerlian GM, Star JA, Hogan J, Canick JA. Comparison of maternal serum total activin A and inhibin A in normal, preeclamptic and nonproteinuric gestationally hypertensive pregnancies. Am J Obstet Gynecol 1999;180:1131-7.
7. Arora DS, Cooke IE, Ganesan TS, et al. Immunohistochemical expression of inhibin/activin subunits in epithelial and granulosa cell tumours of the ovary. J Pathol 1997;181:413-8.
8. Daya D, Sabat L. The use of cytokeratin as a sensitive and reliable marker for trophoblastic tissue. Am J Clin Pathol 1991;95:137-41.
9. Muttukrishna S, Asselin J, Groome NP, Redman CWG, Ledger WL. Serum inhibin A as a marker for pre-eclampsia [Abstract]? September 1997, International Society for Hypertension in Pregnancy, Oxford, UK.
10. Aquilina J, Barnett A, Thompson O, Harrington K. Second-trimester maternal serum inhibin A concentration as an early marker for preeclampsia. Br J Obstet Gynaecol 1999;181:131-6.
11. Cuckle H, Sehmi I, Jones R. Maternal serum inhibin A can predict pre-eclampsia. Br J Obstet Gynaecol 1998;105:1101-3.
12. McCluggage WG, Ashe P, McBride H, Maxwell P, Sloan JM. Localization of the cellular expression of inhibin in trophoblastic tissue. Histopathology 1998;32:252-6.
13. Minami S, Yamoto M, Nakano R. Immunohistochemical localization of inhibin/activin subunits in human placenta. Obstet Gynecol 1992;80:410-4.
14. Shih IM, Kurman RJ. Immunohistochemical localization of inhibin-α in the placenta and gestational trophoblastic lesions. Int J Gynecol Pathol 1999;18:144-50.
15. Wigglesworth JS. The Langhans layer in late pregnancy: a histological study of normal and abnormal cases. J Obstet Gynaecol Br Commonw 1969;69:355-65